News
09-13-2012, 02:50 AM
20/20 GeneSystems, Inc. will present results this week at the Breast Cancer Symposium 2012 (San Francisco) of a 45 patient study showing the usefulness of its PredicTOR test in predicting response of breast tumors to the drug Herceptin.
More... (http://www.news-medical.net/news/20120913/Predicting-breast-cancer-drug-response-by-2020-GeneSystemse28099-PredicTOR-test.aspx)
More... (http://www.news-medical.net/news/20120913/Predicting-breast-cancer-drug-response-by-2020-GeneSystemse28099-PredicTOR-test.aspx)